Table: Haba Laboratories Inc - 6-MTH group results
Nov 11 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2020 Sep 30, 2019 Mar 31, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 6.65 9.53 16.77
(-30.2 pct) (+7.5 pct) (-8.7 pct)
Operating loss 320 mln 1.48 1.52
(+45.2 pct) (-23.9 pct)
Recurring loss 319 mln 1.48 1.50
(+44.8 pct) (-24.1 pct)
Net loss 201 mln 956 mln 1.02
(+43.6 pct) (-22.3 pct)
EPS loss 53.38 yen 243.28 yen 269.73 yen
Ann Div 40.00 yen 40.00 yen
-Q2 div NIL NIL
-Q4 div 40.00 yen 40.00 yen
NOTE - Haba Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T